NO157204C - Fremgangsmaate for fremstilling av galenisk preparat med konstant virkefrigjoering. - Google Patents

Fremgangsmaate for fremstilling av galenisk preparat med konstant virkefrigjoering.

Info

Publication number
NO157204C
NO157204C NO821084A NO821084A NO157204C NO 157204 C NO157204 C NO 157204C NO 821084 A NO821084 A NO 821084A NO 821084 A NO821084 A NO 821084A NO 157204 C NO157204 C NO 157204C
Authority
NO
Norway
Prior art keywords
preparation
active compound
procedure
galenic
calcium
Prior art date
Application number
NO821084A
Other languages
English (en)
Other versions
NO157204B (no
NO821084L (no
Inventor
Heinz Einig
Volker Buehler
Winfried Koch
Joachim Arthur Schwarz
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6129505&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO157204(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO821084L publication Critical patent/NO821084L/no
Publication of NO157204B publication Critical patent/NO157204B/no
Publication of NO157204C publication Critical patent/NO157204C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO821084A 1981-04-07 1982-03-31 Fremgangsmaate for fremstilling av galenisk preparat med konstant virkefrigjoering. NO157204C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813113901 DE3113901A1 (de) 1981-04-07 1981-04-07 Wirkstoffzubereitung zur oralen applikation

Publications (3)

Publication Number Publication Date
NO821084L NO821084L (no) 1982-10-08
NO157204B NO157204B (no) 1987-11-02
NO157204C true NO157204C (no) 1988-02-10

Family

ID=6129505

Family Applications (1)

Application Number Title Priority Date Filing Date
NO821084A NO157204C (no) 1981-04-07 1982-03-31 Fremgangsmaate for fremstilling av galenisk preparat med konstant virkefrigjoering.

Country Status (17)

Country Link
EP (1) EP0063266B1 (no)
JP (1) JPS57175113A (no)
AT (1) ATE14076T1 (no)
AU (1) AU555093B2 (no)
CA (1) CA1184497A (no)
DE (2) DE3113901A1 (no)
DK (1) DK157482A (no)
ES (1) ES511208A0 (no)
FI (1) FI821253L (no)
GR (1) GR74770B (no)
HU (1) HU186855B (no)
IE (1) IE52985B1 (no)
IL (1) IL65328A (no)
NO (1) NO157204C (no)
NZ (1) NZ200244A (no)
PT (1) PT74705B (no)
ZA (1) ZA822327B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4461759A (en) * 1983-01-03 1984-07-24 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of veropamil
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
LU86077A1 (fr) * 1985-09-18 1987-04-02 Pharlyse Sa Nouvelles formes galeniques du verapamil,leur fabrication et medicaments contenant ces nouvelles formes galeniques
LU86099A1 (fr) * 1985-09-30 1987-04-02 Pharlyse Formes galeniques a liberation prolongee du verapamil,leur fabrication et medicaments les contenant
IE58401B1 (en) * 1986-06-20 1993-09-08 Elan Corp Plc Controlled absorption pharmaceutical composition
US4981871A (en) * 1987-05-15 1991-01-01 Abelson Mark B Treatment of ocular hypertension with class I calcium channel blocking agents
US4792452A (en) * 1987-07-28 1988-12-20 E. R. Squibb & Sons, Inc. Controlled release formulation
DE3809764A1 (de) * 1988-03-23 1989-10-05 Knoll Ag Mischung aus alginaten und polyacrylaten und deren verwendung
US5230901A (en) * 1988-03-23 1993-07-27 Knoll Ag Sustained release tablet of a mixture of alginates and polyacrylates
WO1990000391A1 (de) * 1988-07-13 1990-01-25 Knoll Aktiengesellschaft Arzneimittel-depotform auf alginatbasis
US5032406A (en) * 1989-02-21 1991-07-16 Norwich Eaton Pharmaceuticals, Inc. Dual-action tablet
DE3932378A1 (de) * 1989-09-28 1991-04-11 Knoll Ag Feste arzneiform mit hohem verapamil-gehalt
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
US5695781A (en) * 1995-03-01 1997-12-09 Hallmark Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers
US6083532A (en) * 1995-03-01 2000-07-04 Duramed Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers and tablet formed therefrom

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1154810B (de) * 1961-04-01 1963-09-26 Knoll Ag Verfahren zur Herstellung basisch substituierter Phenylacetonitrile
DE1467781A1 (de) * 1963-07-15 1968-12-05 Boehringer Sohn Ingelheim Verfahren zur Herstellung von Dragees mit verlaengerter Wirkstofffreigabe

Also Published As

Publication number Publication date
EP0063266A3 (en) 1983-05-04
DE3113901A1 (de) 1982-10-28
IE820812L (en) 1982-10-07
ZA822327B (en) 1983-03-30
IE52985B1 (en) 1988-04-27
AU555093B2 (en) 1986-09-11
DK157482A (da) 1982-10-08
GR74770B (no) 1984-07-12
NZ200244A (en) 1984-08-24
ES8307496A1 (es) 1983-08-16
PT74705B (en) 1983-11-14
DE3264519D1 (en) 1985-08-08
AU8238482A (en) 1982-10-14
PT74705A (en) 1982-05-01
ES511208A0 (es) 1983-08-16
IL65328A (en) 1985-06-30
JPS57175113A (en) 1982-10-28
IL65328A0 (en) 1982-05-31
ATE14076T1 (de) 1985-07-15
FI821253A0 (fi) 1982-04-07
FI821253L (fi) 1982-10-08
NO157204B (no) 1987-11-02
NO821084L (no) 1982-10-08
EP0063266A2 (de) 1982-10-27
EP0063266B1 (de) 1985-07-03
HU186855B (en) 1985-10-28
CA1184497A (en) 1985-03-26

Similar Documents

Publication Publication Date Title
NO157204C (no) Fremgangsmaate for fremstilling av galenisk preparat med konstant virkefrigjoering.
FI873225A0 (fi) Menetelmä suun kautta annettavan galeenisen naprokseenikoostumuksen valmistamiseksi, josta aktiiviyhdiste vapautuu ohjelmoidusti
ATE154354T1 (de) Azabicyclische verbindungen, diese enthaltende pharmazeutische zubereitungen und ihre therapeutische verwendung
ATE76747T1 (de) Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
EA199900964A1 (ru) Соли сертралина и лекарственные формы с длительным высвобождением сертралина
NO171365C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
DE59410151D1 (de) Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
ATE257704T1 (de) Pharmazeutische zusammensetzungen enthaltend norastemizol.
ES2051834T3 (es) El uso de tetrahidrobenzeno(c,d)indol-6 carboxamidas para la preparacion de un medicamento para el tratamiento de la ansiedad.
KR830002510A (ko) 생물학적 활성화합물과 하이드록시알킬 전분으로 구성되는 조성물
ATE38151T1 (de) Bestaendige 5-adenosyl-l-methionin-salze enthaltende, pharmazeutische zusammensetzungen fuer orale anwendung.
ES475533A1 (es) Un metodo para la preparacion de formas racemicas y optica- mente activas de 2-(4-difenilil)-n-(dimetilamino-alquil)pro-pionamida
KR890004705A (ko) 항바이러스성 제제
FI923662A0 (fi) Terapeutiska medel.
KR870001144A (ko) Nn-디메틸에틸옥사이드가 함유된 약제조성물 및 그의 생산방법
JPS5589221A (en) Antihistaminic agent
KR910018026A (ko) α-페닐-α피리딜알칸산 유도체를 함유하는 배뇨장애증상 치료제
SE8304818L (sv) Medicin med magsarslekande, spasmolytisk och lokalanesteserande verkan
KR890007737A (ko) 진토작용을 하는 약제
KR890001558A (ko) 공황(恐慌) 장애를 경감시키는 제피론 및 이의 약학적 허용 산부가염
SU1282506A1 (ru) 2-(3',4',5'-триметоксифенил)-1-метилимидазо (4,5-с)пиридингидрохлорид, обладающий спазмолитической и гипотензивной активностью
TH3319EX (th) กรรมวิธีสำหรับการเตรียม n-(2-พิริติล)-2-เมทธิล-4-ไฮดรอกซี-2h-1,2-เบนโซไทอะซิน-3-คาร์บอกซะไมด์-1,1ไดออกไซด์